Approximately 70% of breast cancers are estrogen receptor alpha (ERa)-positive.Drugs that target the estrogen receptor have been a mainstay of breast cancer
Skin cancer is the most aggressive and lethal type of skin cancer.To date, there is still the need for reliable molecular prognostic markers for this tumor.